A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation

A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation

Systemic inflammation is related to hyperglycemia in diabetes mellitus (DM). C-C chemokine motif ligand (CCL) 4 is upregulated in type 1 & type 2 DM patients. This study aimed to investigate if CCL4 could be a potential target to improve blood sugar control in different experimental DM model...

Full description

Bibliographic Details
Main Authors:	Ting-Ting Chang, Liang-Yu Lin, Jaw-Wen Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-04-01
Series:	Frontiers in Immunology
Subjects:	blood sugar C-C chemokine motif ligand 4 diabetes mellitus inflammation insulin resistance pancreatic islet cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.650626/full

Similar Items

CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease
by: Ting-Ting Chang, et al.
Published: (2022-09-01)

CCL4 Deletion Accelerates Wound Healing by Improving Endothelial Cell Functions in Diabetes Mellitus
by: Ting-Ting Chang, et al.
Published: (2022-08-01)

C–C motif chemokine ligand 2/C–C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
by: Xiangzi Wang, et al.
Published: (2025-08-01)

α1‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells
by: Lauren J. Albee, et al.
Published: (2017-08-01)

The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors
by: Chao Zhang, et al.
Published: (2017-10-01)

Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients
by: Yuriko Matsushita, et al.
Published: (2021-06-01)

Performance of urinary C-C motif chemokine ligand 14 and the renal resistive index in predicting persistent AKI
by: You Fu, et al.
Published: (2024-12-01)

Epicatechin suppresses the expression of C-C motif chemokine ligand 19 and ameliorates periodontitis
by: Tomomi Sano, et al.
Published: (2024-11-01)

CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
by: Ching Chen, et al.
Published: (2023-07-01)

Correction: CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
by: Ching Chen, et al.
Published: (2023-08-01)

Incidence of C-X-C Motif Chemokine Ligand 10 Overexpression in Pregnant Women Infected with Zika Virus
by: Hafeez Aderinsayo Adekola, et al.
Published: (2024-07-01)

On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update
by: Jordi Camps, et al.
Published: (2021-07-01)

Serum C-C motif ligand 11/Eotaxin-1 may serve as a candidate biomarker for postmenopausal osteoporosis
by: Wang Wen, et al.
Published: (2019-01-01)

C-X3-C motif chemokine ligand 1/receptor 1 regulates the M1 polarization and chemotaxis of macrophages after hypoxia/reoxygenation injury
by: Shuiming Guo, et al.
Published: (2021-12-01)

Potential Impacts of Hydralazine as a Novel Antioxidant on Cardiovascular and Renal Disease—Beyond Vasodilation and Blood Pressure Lowering
by: Ting-Ting Chang, et al.
Published: (2022-11-01)

Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting
by: Jay L. Koyner, et al.
Published: (2024-12-01)

Modification of Tumor Necrosis Factor-α and C-C Motif Chemokine Ligand 18 Secretion by Monocytes Derived from Patients with Diabetic Foot Syndrome
by: Karine O. Galstyan, et al.
Published: (2019-12-01)

CC-chemokine ligand 18, CXC motif chemokine 13 and osteopontin as biomarkers of silicosis and asbestosis: a prospective observational study
by: Na Wu, et al.
Published: (2025-02-01)

Melatonin inhibits bile acids-initiated Cxcl2 expression through JNK/c-Jun signalling pathway
by: TAN Ya, et al.
Published: (2022-04-01)

A review of vaccine effects on women in light of the COVID-19 pandemic
by: Wen-Han Chang
Published: (2020-11-01)

Chemokine (C–C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children
by: Yanjie Shen, et al.
Published: (2022-06-01)

Association of Serum Biomarkers with C-X-C Motif Chemokine Receptor 3 Gene Polymorphism and Severity of Coronavirus-2019 Infection
by: Usha Sachidananda Adiga, et al.
Published: (2024-09-01)

Nerve Growth Factor Enhances Tooth Mechanical Hyperalgesia Through C-C Chemokine Ligand 19 in Rats
by: Rui Guo, et al.
Published: (2021-06-01)

C-X-C Motif Chemokine 12 Was Identified as a Potential Gene Target in the Treatment of Crohn’s Disease
by: Hu H, et al.
Published: (2024-12-01)

XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway
by: Shengqi Wang, et al.
Published: (2019-11-01)

Clinical Significance of Serum Biomarkers: Vascular Endothelial Growth Factor-A and Chemokine (C-X-C motif) Ligand 13 in Egyptian Multiple Myeloma Patients
by: Neemat M. Kassem, et al.
Published: (2023-05-01)

Uric Acid and Impairment of Renal Function in Non-diabetic Hypertensive Patients
by: Yi-Hsin Hung, et al.
Published: (2022-01-01)

C‐C Motif Chemokine Receptor 9 Exacerbates Pressure Overload–Induced Cardiac Hypertrophy and Dysfunction
by: Zhengxi Xu, et al.
Published: (2016-05-01)

The effect of C–C motif chemokine ligand 2 supplementation on in vitro maturation of porcine cumulus-oocyte complexes and subsequent developmental competence after parthenogenetic activation
by: Sohee Kim, et al.
Published: (2023-03-01)

Transcriptional Regulation of Chemokine Genes: A Link to Pancreatic Islet Inflammation?
by: Susan J. Burke, et al.
Published: (2015-05-01)

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
by: Weiwei Yu, et al.
Published: (2021-04-01)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
by: Yi Shi, et al.
Published: (2020-12-01)

Targeting chemoattractant chemokine (C–C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders
by: Yupeng Wang, et al.
Published: (2023-03-01)

Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
by: Shang-Chin Huang, et al.
Published: (2022-05-01)

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4
by: Liru He, et al.
Published: (2018-08-01)

C-X-C Motif Chemokine 10 Contributes to the Development of Neuropathic Pain by Increasing the Permeability of the Blood–Spinal Cord Barrier
by: Hao-Ling Li, et al.
Published: (2020-03-01)

The chemokine CCL14 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma
by: Bai-er Sun, et al.
Published: (2024-07-01)

Single cell transcriptomic analysis of human amnion identifies cell-specific signatures associated with membrane rupture and parturition
by: Wang-Sheng Wang, et al.
Published: (2022-05-01)

Correlation of serum and local CXCL13 levels with disease severity in patients with non-traumatic osteonecrosis of femoral head
by: Yong-Heng Zhao, et al.
Published: (2024-03-01)

Evaluating Serum Levels of Pentraxin-3, von Willebrand Factor and C-X-C Motif Chemokine Ligand 13 as Inflammatory Markers of Unstable Angina Pectoris
by: Fariba Raygan, et al.
Published: (2019-04-01)